Influence of liver‐specific ablation of gp78 E3‐ligase on hepatic cytochrome P450‐ dependent drug metabolism: Clinical implications

Doyoung Kwon,Sung‐Mi Kim,Maria Almira Correia

DOI: https://doi.org/10.1096/fasebj.2018.32.1_supplement.833.1

2018-04-01

The FASEB Journal

Abstract:The autocrine motility factor receptor (AMFR)/gp78 is a membrane‐anchored E3 ligase involved in ubiquitin (Ub)‐dependent proteasomal degradation (UPD). We have previously documented that gp78 is involved in the UPD of two clinically relevant hepatic cytochromes P450 Cyp2E1 and Cyp3A4 engaged in therapeutic drug and/or xenobiotic metabolism. To determine the role of gp78 in the UPD of other hepatic P450s, we generated a liver specific gp78 knockout (KO) mouse model. Cultured primary hepatocytes from KO and wild type (WT) mice were untreated or treated with P450 inducer β‐naphthoflavone (Cyp1a2), phenobarbital (Cyps2a, 2b and 2c), isoniazid (Cyp2e1) or dexamethasone (Cyp3a). Immunoblotting and selective functional marker analyses revealed that the functional content of Cyps1a2, 2a, 2c, 2e1 and 3a was increased, but that of Cyp2b or Cyp2d was decreased/unchanged in KO relative to WT. To determine the potential clinical relevance of these findings, the in culture metabolism of tamoxifen, a breast cancer chemotherapeutic prodrug, to its active metabolite endoxifen was monitored by LC/MS. Upon 8 h of tamoxifen incubation, the levels of Cyp3a‐generated metabolites N‐desmethyltamoxifen and endoxifen were significantly increased in KO over WT hepatocytes, but the Cyp2d‐generated metabolite 4‐hydroxytamoxifen was unchanged, consistent with the corresponding functional levels of hepatic Cyps3a and 2d. Collectively, our findings reveal that hepatic gp78 deficiency significantly increased the functional levels of several drug‐metabolizing P450s most likely by impairing their UPD. These increases in turn enhanced the hepatic metabolic activation of a clinically relevant anti‐cancer drug. Because gp78 genetic polymorphisms exist, and gp78 is overexpressed in certain malignant tumors and human cancers (i.e. breast and colon) that correlates well with their progression and poor prognosis, our findings suggest that gp78 be considered a significant modulator of P450‐mediated metabolism of clinically relevant/chemotherapeutic drugs and associated drug‐drug interactions. Support or Funding Information Supported by NIH grants GM44037, DK26506 and DK26743. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

cell biology,biochemistry & molecular biology,biology